TRVN - Trevena, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Trevena, Inc.

955 Chesterbrook Boulevard
Suite 110
Chesterbrook, PA 19087
United States
610-354-8840
http://www.trevena.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees29

Key Executives

NameTitlePayExercisedYear Born
Ms. Carrie L. BourdowPres, CEO & Director1.62MN/A1963
Dr. Mark A. DemitrackSr. VP & Chief Medical Officer784.28kN/A1958
Dr. Howard A. Rockman M.D.Scientific Founder, Consultant and Member of Scientific Advisory BoardN/AN/AN/A
Mr. John P. HamillVP of Fin.N/AN/A1964
Erin ClarkSr. Director of Corp. Strategy & Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatment options that target and treat diseases affecting the central nervous system. Its product candidates include Oliceridine injection, a G protein biased mu-opioid receptor (MOR) ligand that has completed Phase III clinical trials for the management of moderate-to-severe acute pain where intravenous administration is warranted; TRV250, a G protein biased delta- opioid receptor ligand, which is in Phase I clinical study for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR that has completed Phase I clinical study for the treatment of moderate-to-severe acute and chronic pain; TRV027 for the treatment of acute heart failure; and TRV045, a novel S1P modulator for managing chronic pain. The company was founded in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Corporate Governance

Trevena, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.